Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

June 15, 2006 (Vol. 26, No. 12)

Focus on Mid-Densities Drives Multiplex Arrays

Arrays for In vitro Diagnostics, Toxicology, Dose Response, and Biomarker Discovery

  • The maturing microarray market is less about numbers than quality of information. As users complete their high-throughput, whole-genome array work, looking at hundreds of thousands of analytes, the need to focus on subsets of those analytes is building a market for mid- and low-density panels built around disease states ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.